| scholarly article | Q13442814 |
| P2093 | author name string | Karin N | |
| Maor G | |||
| Wildbaum G | |||
| Youssef S | |||
| Grabie N | |||
| Gour-Lavie A | |||
| P2860 | cites work | Chemokines and T lymphocytes: more than an attraction | Q47713299 |
| Prevention of experimental autoimmune encephalomyelitis by MIP-1alpha and MCP-1 naked DNA vaccines | Q48140731 | ||
| Long-lasting protective immunity to experimental autoimmune encephalomyelitis following vaccination with naked DNA encoding C-C chemokines. | Q48371576 | ||
| Anti-arthritic effects demonstrated by an interleukin-2 receptor-targeted cytotoxin (DAB486IL-2) in rat adjuvant arthritis | Q68194434 | ||
| Myelin-liposome protection against experimental autoimmune encephalomyelitis is associated with reduced neuroantigen-specific T-cell-mediated responses | Q70541168 | ||
| DNA vaccines | Q71504602 | ||
| An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis | Q71829114 | ||
| DNA vaccines | Q72989814 | ||
| Development of arthritis, periarthritis and periostitis in rats given adjuvants | Q73940011 | ||
| Streptococcal cell wall-induced arthritis: requirements for IL-4, IL-10, IFN-gamma, and monocyte chemoattractant protein-1 | Q74506235 | ||
| Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses | Q77723690 | ||
| The role of an epithelial neutrophil-activating peptide-78-like protein in rat adjuvant-induced arthritis | Q77841725 | ||
| Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization | Q24599495 | ||
| Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis | Q28239197 | ||
| Chemokines | Q29616435 | ||
| Role of cytokines in rheumatoid arthritis | Q29620713 | ||
| Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. | Q34325931 | ||
| Immunostimulatory DNA sequences necessary for effective intradermal gene immunization | Q34384185 | ||
| Therapeutic vaccination against adjuvant arthritis using autoimmune T cells treated with hydrostatic pressure | Q34635952 | ||
| An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model | Q36380336 | ||
| Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. | Q36438020 | ||
| Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model | Q37383845 | ||
| Rheumatoid arthritis. Pathophysiology and implications for therapy | Q38019708 | ||
| Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis | Q40587405 | ||
| Biologic agents for treating rheumatoid arthritis. Concepts and progress | Q41398093 | ||
| Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis | Q41430466 | ||
| Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritis. | Q42644475 | ||
| Heterologous protection against influenza by injection of DNA encoding a viral protein | Q43828996 | ||
| Genetic immunization is a simple method for eliciting an immune response | Q43857336 | ||
| Augmentation of natural immunity to a pro-inflammatory cytokine (TNF-alpha) by targeted DNA vaccine confers long-lasting resistance to experimental autoimmune encephalomyelitis | Q45861565 | ||
| Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. | Q46109491 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 361-371 | |
| P577 | publication date | 2000-08-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis | |
| P478 | volume | 106 |
| Q40470539 | A DNA vaccine encoding genetic fusions of carcinoembryonic antigen (CEA) and granulocyte/macrophage colony-stimulating factor (GM-CSF). |
| Q40490993 | Active immunization against murine TNFalpha peptides in mice: generation of endogenous antibodies cross-reacting with the native cytokine and in vivo protection. |
| Q35066456 | Adjuvant activity of the catalytic A1 domain of cholera toxin for retroviral antigens delivered by GeneGun |
| Q36327377 | Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptides |
| Q55259964 | Autoantibodies to Chemokines and Cytokines Participate in the Regulation of Cancer and Autoimmunity. |
| Q36139951 | Autoantigens act as tissue-specific chemoattractants. |
| Q79291232 | Beneficial autoimmunity to proinflammatory mediators restrains the consequences of self-destructive immunity |
| Q38666452 | Biased signaling pathways via CXCR3 control the development and function of CD4+ T cell subsets |
| Q54745308 | Chemokine receptor CCR5 is not required for development of experimental autoimmune gastritis. |
| Q34418051 | Chemokines in autoimmune disease |
| Q36167475 | Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies |
| Q52691045 | DEC205-DC targeted DNA vaccine against CX3CR1 protects against atherogenesis in mice. |
| Q37368644 | DNA vaccine containing the mycobacterial hsp65 gene prevented insulitis in MLD-STZ diabetes. |
| Q37723178 | Dual targeting of CCR2 and CCR5: therapeutic potential for immunologic and cardiovascular diseases |
| Q36627931 | Effects of MIP-1 alpha, MIP-3 alpha, and MIP-3 beta on the induction of HIV Gag-specific immune response with DNA vaccines |
| Q95781067 | Effects of MIP-1α, MIP-3α, and MIP-3β on the Induction of HIV Gag-specific Immune Response with DNA Vaccines |
| Q37340457 | Emerging applications of anticytokine vaccines |
| Q42834113 | Human chemokine MIP1α increases efficiency of targeted DNA fusion vaccines |
| Q45722955 | Immunogenicity of DNA vaccines that direct the coincident expression of the 120 kDa glycoprotein of human immunodeficiency virus and the catalytic domain of cholera toxin. |
| Q35053404 | Neutralizing antibodies in gene-defective hosts |
| Q84534177 | Peripheral blood T4 cell surface CCR5 density as a marker of activity in rheumatoid arthritis treated with anti-CD20 monoclonal antibody |
| Q41603563 | Pharmacological blockade of CCR1 ameliorates murine arthritis and alters cytokine networks in vivo |
| Q40247465 | Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines. |
| Q35827348 | Reduced tumourigenicity of EG7 after RANTES gene transfer and the underlying mechanism |
| Q35195561 | Role of CCL3/MIP-1alpha and CCL5/RANTES during acute Trypanosoma cruzi infection in rats |
| Q35115839 | Subversion of the chemokine world by microbial pathogens |
| Q38148785 | Targeting CCL5 in inflammation |
| Q35056023 | Targeting monocyte chemoattractant protein-1 signalling in disease |
| Q36801049 | The Development of Novel Therapies for Rheumatoid Arthritis |
| Q26773127 | The Role of Chemokines in Shaping the Balance Between CD4(+) T Cell Subsets and Its Therapeutic Implications in Autoimmune and Cancer Diseases |
| Q36256348 | The catalytic A1 domains of cholera toxin and heat-labile enterotoxin are potent DNA adjuvants that evoke mixed Th1/Th17 cellular immune responses |
| Q36096959 | The complex role of the chemokine receptor CCR2 in collagen-induced arthritis: implications for therapeutic targeting of CCR2 in rheumatoid arthritis |
| Q37760665 | The multiple faces of CXCL12 (SDF-1alpha) in the regulation of immunity during health and disease |
| Q35144038 | Therapeutic vaccination to block receptor-ligand interactions |
| Q51959805 | Vaccination with combination of Fit3L and RANTES in a DNA prime-protein boost regimen elicits strong cell-mediated immunity and antitumor effect. |
| Q35122178 | Vectors for the treatment of autoimmune disease. |
Search more.